Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.
 
/s/ Aditya P. Mohanty
   
/s/ Baruch Halpert
BioTime Inc.
   
HBL-Hadasit Bio-Holdings Ltd.
 
Name:
Aditya O. Mohanty
 
Name:
Baruch Halpert
Title:
Co-CEO
 
Title:
Chairman
 
1010 Atlantic Ave., Suite 102
 
Jerusalem Bio-Park, 5th Floor
Alameda, CA 94501
 
Hadassah Ein-Kerem Campus,
USA
 
Jerusalem 91120
   
Israel
 
Facsimile:
 
     
E-mail:
 
   
Facsimile:
 
 
Attn:
 
   
E-mail:
 
 
   
Attn:
   
 
 
/s/ Rami Skaliter
 
 
Cell Cure Neurosciences Ltd.
 
     
 
Name:
Rami Skaliter
 
 
Title:
Chief Scientific Officer
 
 
 
P.O. Box 12000
 
JBP Bldg, 5th floor
 
Hadassah Ein Kerem
 
Hebrew University of Jerusalem,
 
Ein Kerem, Jerusalem 91120
 
Israel
 
Facsimile: 02-642-9856
 
E-mail:
 
 
 
Attn: CEO

[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
12

© Copyright BioTime, Inc.